Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
It’s crucial to get the entire picture of the potential benefits and risks of treatment.
The novel immune-enhancing antibody delays disease progression, especially in people with a common genetic variant.
This held true regardless of whether statins were taken before or after the cancer diagnosis.
Study sheds light on the inverse association between cancer and Alzheimer’s disease.
Researchers analyzed health data regarding modern hep C treatments specific to New South Wales.
Targeted therapy combination reduced the risk of disease progression or death by 65% in a randomized study.
First nuclear export inhibitor gets the nod for patients lacking treatment options.
Researchers reached this conclusion after reviewing data on more than 30,000 people.
Widespread vaccination could potentially eliminate cervical, anal, oral and other HPV-related cancers.
European and U.S. guidelines recommend that all those with cirrhosis undergo biannual screening for liver cancer.
Phase III study misses statistical threshold, but the immunotherapy appears to show some benefit.
The CDC analyzed data from before and after the introduction of the Gardasil vaccine for human papillomavirus.
RET inhibitor shrank tumors in more than half of people with non-small-cell lung cancer and aggressive thyroid cancer.
Study in China sees an association with several cancer types, especially gastrointestinal malignancies.
The test was able to identify many cancers, and their location, at early stages.
New immunotherapy option approved for uncommon, aggressive type of lung cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.